LY 163502

Known as: LY-163502 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1989-1996
01219891996

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1996
1996
A number of studies have recently suggested that the D3 receptor [ 11 is located presynaptically and functions as an autoreceptor… (More)
  • table I
  • figure I
  • figure 2
Is this relevant?
1991
1991
The D2 dopamine receptor agonist quinelorane (LY-163502), microinjected into the paraventricular nucleus (PVN), affected genital… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • table 1
Is this relevant?
1991
1991
This study investigated the effects on genital reflexes of unilateral MPOA injections of 0.1, 1, 3, and 10 micrograms of the D2… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1990
1990
Systemic administration of direct and indirect dopamine agonists resulted in increased extracellular ascorbic acid levels in the… (More)
Is this relevant?
1990
1990
Studies were undertaken to clarify further the mechanism(s) of action of the atypical neuroleptic clozapine, using a behavioural… (More)
Is this relevant?
1989
1989
The D1/D2 dopamine agonist apomorphine, microinjected into the medial preoptic area (MPOA), facilitates male rat sexual behavior… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
Is this relevant?
1989
1989
The effect of dopamine D-1 and D-2 receptor stimulation on body temperature has been investigated in male mice. The selective D-2… (More)
Is this relevant?